Help Everyone Assess Risk Today: LEnten Nutrition Study (HEART-LENS)
African American Health and Nutrition Intervention: Help Everyone Assess Risk Today: LEnten Nutrition Study (HEART-LENS) "Giving up Unhealthy Food for Lent"
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to evaluate the impact of community health screening, health education and nutritional intervention on risk factors for cardiovascular disease in a predominantly African American population. The health fair and intervention will take place in a church that typically improves their lifestyle by "giving up for Lent" certain foods or habits. Participation in this nutrition intervention is voluntary and each participant will sign an informed consent along with a waiver. On the waiver, the participant can agree to have all testing performed but can withdraw consent at any time or decide to have only some of the testing. It was hypothesized that a community-based health screening and nutritional intervention will have a positive impact on the participants by:
- 1.Measuring baseline risk factors
- 2.Educating them about their individual risk for heart disease
- 3.Providing education on healthy lifestyle
- 4.Providing a nutritional intervention for 40 days with home- delivered plant-based meals nutrition that has been shown to lower cardiac risk factors
- 5.Repeating the risk factor assessment at the end of the intervention, to demonstrate the degree of, if any, reduction in cardiac risk as assessed by the American College of Cardiology/American Heart Association (ACC/AHA) Atherosclerotic Cardiovascular Disease (ASCVD) Risk Calculator
- 6.Motivating at-risk subjects to seek continued appropriate medical care and to institute more permanent relevant lifestyle changes (e.g., diet, exercise, medication compliance).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2020
CompletedFirst Submitted
Initial submission to the registry
August 9, 2021
CompletedFirst Posted
Study publicly available on registry
September 27, 2021
CompletedOctober 1, 2021
September 1, 2021
2 months
August 9, 2021
September 25, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
American College of Cardiology/American Heart Association (ACC/AHA) Atherosclerotic Cardiovascular Disease (ASCVD) Risk Calculator, ranging from 1% to 50% 10-year event risk
ACC/AHA Guideline for Prevention Tool calculated based on blood pressure, total cholesterol, HDL cholesterol, diabetes, age, gender, ethnicity, and smoking history.
5 weeks
Study Arms (1)
Intervention
EXPERIMENTALVegan food for 5 weeks: approximately 50 participants volunteered for the intervention.
Interventions
Eligibility Criteria
You may qualify if:
- Age \>18
- Able to consent to dietary protocol
- Willing to comply with study requirements and voluntarily agrees to participate in this clinical study after appropriate informed consent is provided.
You may not qualify if:
- Vegetarians
- Inability to regularly measure blood pressure if taking antihypertensive medications
- Inability to regularly measure blood sugar if taking antihyperglycemic medications
- Celiac disease (gluten enteropathy)
- Treatment for eating disorder
- Active treatment for malignancy
- Inability to eat solid food
- Fruit, nut or vegetable
- Age \>18
- Able to consent to dietary protocol
- Willing to comply with study requirements and voluntarily agrees to participate in this clinical study after appropriate informed consent is provided.
- Vegetarians
- Inability to regularly measure blood pressure if taking antihypertensive medications
- Inability to regularly measure blood sugar if taking antihyperglycemic medications
- Celiac disease (gluten enteropathy)
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rush University Medical Center
Chicago, Illinois, 60612, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief, Cardiology Division, James B. Herrick Professor of Medicine
Study Record Dates
First Submitted
August 9, 2021
First Posted
September 27, 2021
Study Start
March 3, 2019
Primary Completion
April 20, 2019
Study Completion
March 20, 2020
Last Updated
October 1, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share